Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Report: $300M Lilly, Cadila cardio pact faces possible termination
Report: $300M Lilly, Cadila cardio pact faces possible termination
Report: $300M Lilly, Cadila cardio pact faces possible termination
Submitted by
admin
on January 3, 2012 - 12:54pm
Source:
Fierce Biotech
News Tags:
Eli Lilly
Cadila
India
Headline:
Report: $300M Lilly, Cadila cardio pact faces possible termination
Do Not Allow Advertisers to Use My Personal information
